GUO Zhi-Li, GU Jun, MI Qing-Sheng, XIAO Fei. Effects of Leflunomide on the Proliferation and Apoptosis of Human Keratinocytes[J].Chinese Journal of Dermatology, 2003, 36(10): 580-582.
[1] Wallace D. Current and emerging lupus treatments. Am J Manag Care, 2001, 7( 16 Suppl):S490-S495. [2] Reich K, Hummel KM, Beckmann I, et al. Treatment of severe psoriasis and psoriatic arthritis with leflunomide. Br J Dermatol, 2002,146: 335-336. [3] Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol,1989, 134:733-739. [4] Stein M, Bernd A, Ramirez-Bosca A, et al. Measurement of anti-inflammatory effects of glucocorticoids on human keratinocytes in vitro. Comparison of normal human keratinocytes with the keratinocyte cell line HaCaT. Arzneimittelforschung, 1997, 47:1266-1270. [5] Fuchs E. Epidermal differentiation. Curr Opin Cell Biol, 1990, 2:1028-1035. [6] Fox RI, Herrmann ML, Frangou CG, et al. Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol, 1999, 93:198-208.